News Cegedim

Equities

CGM

FR0000053506

Real-time Euronext Paris Other stock markets 09:50:33 2024-04-18 am EDT			5-day change	1st Jan Change
13.85 ^EUR	-1.07%		-1.07%	-22.45%

Mar. 28	Cegedim: 23% increase in ROC in 2023	CF
Mar. 27	Transcript : Cegedim SA, 2023 Earnings Call, Mar 27, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cegedim: Release of its 2023 Universal Registration Document	Apr. 04	GL
Cegedim: 23% increase in ROC in 2023	Mar. 28	CF
Transcript : Cegedim SA, 2023 Earnings Call, Mar 27, 2024	Mar. 27
Cegedim Full year 2023 results: Revenue and recurring operating income both up	Mar. 27	GL
Cegedim Full year 2023 results: Revenue and recurring operating income both up	Mar. 27	AQ
Cegedim SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Cegedim: acquisition in the dental care sector	Feb. 16	CF
Cegedim Buys French Dental Software Company Visiodent	Feb. 16	MT
Cegedim: acquisition of Visiodent group	Feb. 15	GL
Cegedim: acquisition of Visiodent group	Feb. 15	AQ
Cegedim: certification obtained for data centers	Feb. 02	CF
Cegedim: 8% sales growth in Q4	Jan. 26	CF
Cegedim: Revenues grew 10.9% in 2023	Jan. 25	GL
Cegedim: Revenues grew 10.9% in 2023	Jan. 25	AQ
Half-year liquidity contract statement for CEGEDIM	Jan. 09	GL
Cegedim: investment in start-up Phealing	Nov. 30	CF
Cegedim SA acquired unknown majority stake in Phealing.	Nov. 29	CI
Cegedim: THIN database extended to Germany	Nov. 13	CF
Cegedim : Release Cegedim Health Data sets up THIN® EuroBoard, its first European scientific review committee dedicated to healthcare research using real-world data	Nov. 06	PU
Cegedim: Growth continued in third quarter 2023	23-10-26	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer